全文获取类型
收费全文 | 427597篇 |
免费 | 26331篇 |
国内免费 | 1034篇 |
专业分类
耳鼻咽喉 | 5812篇 |
儿科学 | 13609篇 |
妇产科学 | 12562篇 |
基础医学 | 61831篇 |
口腔科学 | 10342篇 |
临床医学 | 37059篇 |
内科学 | 82642篇 |
皮肤病学 | 8027篇 |
神经病学 | 32601篇 |
特种医学 | 16837篇 |
外国民族医学 | 43篇 |
外科学 | 67682篇 |
综合类 | 9594篇 |
现状与发展 | 2篇 |
一般理论 | 332篇 |
预防医学 | 31906篇 |
眼科学 | 9806篇 |
药学 | 30178篇 |
2篇 | |
中国医学 | 961篇 |
肿瘤学 | 23134篇 |
出版年
2021年 | 4677篇 |
2019年 | 4569篇 |
2018年 | 6426篇 |
2017年 | 4690篇 |
2016年 | 5196篇 |
2015年 | 6076篇 |
2014年 | 8422篇 |
2013年 | 13042篇 |
2012年 | 17612篇 |
2011年 | 18576篇 |
2010年 | 11204篇 |
2009年 | 10198篇 |
2008年 | 16802篇 |
2007年 | 18216篇 |
2006年 | 17671篇 |
2005年 | 17408篇 |
2004年 | 16798篇 |
2003年 | 15806篇 |
2002年 | 15230篇 |
2001年 | 14555篇 |
2000年 | 14652篇 |
1999年 | 12764篇 |
1998年 | 4598篇 |
1997年 | 4055篇 |
1996年 | 3854篇 |
1995年 | 3720篇 |
1994年 | 3352篇 |
1993年 | 3174篇 |
1992年 | 9128篇 |
1991年 | 9281篇 |
1990年 | 8972篇 |
1989年 | 8766篇 |
1988年 | 8033篇 |
1987年 | 7777篇 |
1986年 | 7441篇 |
1985年 | 7306篇 |
1984年 | 5635篇 |
1983年 | 4957篇 |
1982年 | 3571篇 |
1981年 | 3184篇 |
1979年 | 5036篇 |
1978年 | 3875篇 |
1977年 | 3312篇 |
1976年 | 3000篇 |
1975年 | 3289篇 |
1974年 | 3804篇 |
1973年 | 3780篇 |
1972年 | 3406篇 |
1971年 | 3251篇 |
1970年 | 3099篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
A V Pokrovski? P O Kazanchian G I Kuntsevich V L Buianovski? M A Vikhert 《Vestnik khirurgii imeni I. I. Grekova》1986,137(9):56-64
Results of an examination of 39 patients are described and critically assessed. An analysis of the resolving power of the method of ultrasonic angiography in pathological formations of major vessels of the neck is given. 相似文献
102.
103.
A. Roosaar L. Yin G. Sandborgh-Englund O. Nyrén T. Axéll 《Journal of oral pathology & medicine》2006,35(5):257-261
OBJECTIVES: The aim was to assess the natural course of oral lichen lesions (OLL) among unselected, non-consulting individuals. SUBJECTS AND METHODS: A cohort of 327 subjects with OLL, confirmed in 1973-1974 during a population-based survey in two Swedish municipalities, was followed through January 2002 via record linkages with nationwide and essentially complete registers. A sample of 80 drawn from the 194 surviving subjects who still resided in the area in 1993-1995 was invited for interview and oral re-examination. RESULTS: At the end of follow-up, one case of oral cancer was detected, while 0.4 were expected. The overall mortality among subjects with OLL was not significantly different from that in the 15,817 OLL-free subjects who participated in the initial population based survey in 1973-1974. The lesion had disappeared in 14 (39%) of 36 re-examined subjects with white OLLs in 1973-1974, and four (11%) had transformed into red types. In the corresponding group of 19 with red forms initially, five (26%) had become lesion free and four (21%) had switched to white types. Although the cohort size does not permit firm conclusions regarding oral cancer risk, the natural course over up to 30 years appears to be benign in the great majority. 相似文献
104.
105.
106.
Dnyanesh N Tipre James J Fox Daniel P Holt Gilbert Green Jianhua Yu Martin Pomper Robert F Dannals Frank M Bengel 《Journal of nuclear medicine》2008,49(7):1189-1195
The sympathetic nervous system of the heart plays a key role in the pathophysiology of various cardiac diseases. Small-animal models are valuable for obtaining further insight into mechanisms of cardiac disease and therapy. To determine the translational potential of cardiac neuronal imaging from rodents to humans, we characterized the rat sympathetic nervous system using 3 radiotracers that reflect different subcellular mechanisms: (11)C-meta-hydroxyephedrine (HED), a tracer of neuronal transport showing stable uptake and no washout in healthy humans; (11)C-phenylephrine (PHEN), a tracer of vesicular leakage and intraneuronal metabolic degradation with initial uptake and subsequent washout in humans; and (11)C-epinephrine (EPI), a tracer of vesicular storage with stable uptake and no washout in humans. METHODS: We used a small-animal PET system to study healthy male Wistar rats at baseline, after desipramine (DMI) pretreatment (DMI block), and with DMI injection 15 min after tracer delivery (DMI chase). The rats were kept under general isoflurane anesthesia while dynamic emission scans of the heart were recorded for 60 min after radiotracer injection. A myocardial retention index was determined by normalizing uptake at 40 min to the integral under the arterial input curve. Washout rates were determined by monoexponential fitting of myocardial time-activity curves. RESULTS: At baseline, HED showed high myocardial uptake and sustained retention, EPI showed moderate uptake and significant biphasic washout, and PHEN showed moderate uptake and monoexponential washout. The average (+/- SD) left ventricular retention index for HED, PHEN, and EPI was 7.38% +/- 0.82%/min, 3.43% +/- 0.45%/min, and 4.24% +/- 0.59%/min, respectively; the washout rate for HED, PHEN, and EPI was 0.13% +/- 0.23%/min, 1.13% +/- 0.35%/min, and 0.50% +/- 0.24%/min, respectively. The DMI chase resulted in increased washout only for HED. DMI block decreased myocardial uptake of all tracers by less than 90%. CONCLUSION: Kinetic profiles of HED in the rat myocardium were similar to those of HED in humans, suggesting comparable neuronal transport density. Unlike in humans, however, significant washout of EPI and faster washout of PHEN were encountered, consistent with high intraneuronal metabolic activity, high catecholamine turnover, and reduced vesicular storage. This evidence of increased neuronal activity in rodents has implications for translational studies of cardiac neuronal biology in humans. 相似文献
107.
108.
109.
FDA’S Perspectives on Cardiovascular Devices 总被引:1,自引:0,他引:1
Eric A. Chen Sonna M. Patel-Raman Kathryn O’Callaghan Matthew G. Hillebrenner 《Journal of cardiovascular translational research》2009,2(2):143-146
The Food and Drug Administration (FDA) decision process for approving or clearing medical devices is often determined by a
review of robust clinical data and extensive preclinical testing of the device. The mission statement for the Center for Devices
and Radiological Health (CDRH) is to review the information provided by manufacturers so that it can promote and protect the
health of the public by ensuring the safety and effectiveness of medical devices deemed appropriate for human use (Food, Drug
& Cosmetic Act, §903(b)(1, 2(C)), December 31, 2004; accessed December 17, 2008 ). For high-risk devices, such as ventricular assist devices (VADs), mechanical heart valves, stents, cardiac resynchronization
therapy (CRT) devices, pacemakers, and defibrillators, the determination is based on FDA’s review of extensive preclinical
bench and animal testing followed by use of the device in a clinical trial in humans. These clinical trials allow the manufacturer
to evaluate a device in the intended use population. FDA reviews the data from the clinical trial to determine if the device
performed as predicted and the clinical benefits outweigh the risks. This article reviews the regulatory framework for different
marketing applications related to cardiovascular devices and describes the process of obtaining approval to study a cardiovascular
device in a U.S. clinical trial. 相似文献
110.
Hong Wang Venkatraman Siddharthan Jeffery O. Hall John D. Morrey 《Journal of neurovirology》2009,15(4):293-299
Prior findings led us to hypothesize that West Nile virus (WNV) preferentially transports along motor axons instead of sensory
axons. WNV is known to undergo axonal transport in cell culture and in infected hamsters to infect motor neurons in the spinal
cord. To investigate this hypothesis, WNV was injected directly into the left sciatic nerve of hamsters. WNV envelope-staining
in these hamsters was only observed in motor neurons of the ipsilateral ventral horn of the spinal cord, but not in the dorsal
root ganglion (DRG). To evaluate the consequence of motor neuron infection by WNV, the authors inoculated wheat germ agglutinin—horseradish
peroxidase (WGA-HRP) 9 days after WNV sciatic nerve injection, and stained the spinal cord and the DRG for HRP activity 3
days later. The degree of HRP-staining in DRG was the same in WNV- and sham-infected animals, but the HRP-staining in the
motor neuron in the ventral horn was considerably less for WNV-infected hamsters. To investigate the mechanism of WNV transport,
hamsters were treated with colchicine, an inhibitor of membranous microtubule-mediated transport. The intensity of the WNV-stained
area in the spinal cord of colchicine-treated hamsters at 6 days after WNV infection were significantly reduced (P≤.05) compared to the placebo-treated hamsters. These data suggest that WNV is preferentially transported through the motor
axons, but not the sensory axons, to subsequently infect motor neurons and cause motor weakness and paralysis. 相似文献